Kloke O, Haubeck H D, Kölsch E
Eur J Immunol. 1986 Jun;16(6):659-64. doi: 10.1002/eji.1830160612.
The BALB/c plasmacytoma ADJ-PC-5 induces in early stages of tumorigenesis specific T suppressor (Ts) cells apparently as the first reaction of the immune system towards the growing tumor. In attempts to apply the concept of early induction of Ts cells in neoplasia for the induction of tolerance to allografts we have tried to induce Ts cells against alloantigens by injecting allogeneic spleen cells in doses increasing exponentially from 10 to 10(5) cells/mouse. Experiments using various strain combinations failed to demonstrate induction of specific Ts cells by this procedure. To explain the apparent discrepancy between these and the tumor data the capacity of the ADJ-PC-5 tumor cells to induce Ts cells in allogeneic combinations was analyzed. ADJ-PC-5 cells are capable of inducing specific Ts cells in CBA/J mice. These Ts cells specifically suppress the induction of a primary cytotoxic T cell response of CBA/J spleen cells against BALB/c, BALB.B and (BALB/c X C57BL/6)F1 cells but not one against B10.D2 or C57BL/10 target cells. The ADJ-PC-5-induced CBA/J Ts cells have been further analyzed using a panel of different target or responder cells. From these experiments the following conclusions can be drawn: the CBA/J Ts cells are specific for an antigen which is shared by ADJ-PC-5 and normal BALB/c spleen cells. The antigen in question is not coded for by the H-2d major histocompatibility complex. The data suggest that the Ts cell-inducing antigen on ADJ-PC-5 tumor cells is not a tumor associated neoantigen but a self antigen also present on normal BALB/c lymphoid cells.
BALB/c浆细胞瘤ADJ-PC-5在肿瘤发生的早期诱导产生特异性抑制性T细胞(Ts细胞),这显然是免疫系统对生长中的肿瘤的第一反应。为了将肿瘤形成过程中早期诱导Ts细胞的概念应用于诱导对同种异体移植物的耐受性,我们试图通过以指数方式从每只小鼠10个细胞增加到10(5)个细胞的剂量注射同种异体脾细胞来诱导针对同种异体抗原的Ts细胞。使用各种品系组合的实验未能证明通过该程序诱导出特异性Ts细胞。为了解释这些结果与肿瘤数据之间明显的差异,分析了ADJ-PC-5肿瘤细胞在同种异体组合中诱导Ts细胞的能力。ADJ-PC-5细胞能够在CBA/J小鼠中诱导特异性Ts细胞。这些Ts细胞特异性抑制CBA/J脾细胞对BALB/c、BALB.B和(BALB/c×C57BL/6)F1细胞的原发性细胞毒性T细胞反应,但不抑制对B10.D2或C57BL/10靶细胞的反应。使用一组不同的靶细胞或反应细胞对ADJ-PC-5诱导的CBA/J Ts细胞进行了进一步分析。从这些实验中可以得出以下结论:CBA/J Ts细胞对ADJ-PC-5和正常BALB/c脾细胞共有的一种抗原具有特异性。所讨论的抗原不是由H-2d主要组织相容性复合体编码的。数据表明,ADJ-PC-5肿瘤细胞上诱导Ts细胞的抗原不是肿瘤相关新抗原,而是正常BALB/c淋巴细胞上也存在的自身抗原。